Elsilimomab (Anti-IL-6 / IFNb2) | Interleukins antibody | Read Reviews & Product Use Citations

Elsilimomab (Anti-IL-6 / IFNb2) is an IgG1 monoclonal antibody against interleukin-6 (IL-6), with a KD of 22 pM and an IC50 of 1.4 nM. Elsilimomab has the potential to be used in research of multiple myeloma, renal cell carcinoma, and rheumatoid arthritis (RA). MW : 145.96 KD.

Purity & Quality Control

Batch: A284501 Purity: 99% Protein concentration: 5.45mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective Interleukins Inhibitors

Biological Activity

Description	Elsilimomab (Anti-IL-6 / IFNb2) is an IgG1 monoclonal antibody against interleukin-6 (IL-6), with a KD of 22 pM and an IC50 of 1.4 nM. Elsilimomab has the potential to be used in research of multiple myeloma, renal cell carcinoma, and rheumatoid arthritis (RA). MW : 145.96 KD.

References
[1] Lee JJ, et al. Mol Ther. 2014;22(7):1254-1265.

References

[1] Lee JJ, et al. Mol Ther. 2014;22(7):1254-1265.

Product Details

CAS No.	468715-71-1
Molecular Weight	145.96
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field